Latest News and Press Releases

MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis.

MediPharm announces it will release its second quarter 2025 financial results before markets open on Thursday, August 14th, 2025.

MediPharm Labs Launches New Shake & Puff CBN THC Nighttime Metered Dose Inhaler in Canada.

MediPharm Announces Election of All Seven Company Director Nominees at 2025 Annual and Special Meeting of Shareholders.

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based...

Independent proxy advisor Glass Lewis recommends that MediPharm shareholders vote for all of the Company's director nominees.

MediPharm reminds shareholders to vote for proven strategy and team in advance of deadline, July 13, 2025 at 3:00pm EDT.

Ontario Superior Court of Justice fully dismisses application by dissident shareholder Apollo against MediPharm Labs.

MediPharm closes sale of Hope, BC facility and expands international cultivation capacity at EU GMP-certified facility in Napanee, ON.

ISS recommends that shareholders vote the GREEN proxy FOR ALL MediPharm director nominees; REJECTS Apollo’s arguments and director slate.